Published in NeuroRehabilitation on January 01, 2004
The vegetative state--a syndrome in search of a name. J Med Life (2012) 0.80
Sleep disorders in patients with end-stage renal disease undergoing dialysis therapy. Nephrol Dial Transplant (2005) 2.12
Drugs with anticholinergic properties as a risk factor for cognitive impairment in elderly people: a population-based study. J Clin Psychopharmacol (2008) 1.54
Association of restless legs syndrome in type 2 diabetes: a case-control study. Sleep (2007) 1.41
Restless legs syndrome in end-stage renal disease. Sleep Med (2004) 1.35
Drugs with anticholinergic properties: cognitive and neuropsychiatric side-effects in elderly patients. Neurol Sci (2009) 0.95
Incidence of transient ischemic attack and early stroke risk: validation of the ABCD2 score in an Italian population-based study. Stroke (2011) 0.95
A case-control study on restless legs syndrome in nondialyzed patients with chronic renal failure. Mov Disord (2010) 0.86
Sleep disturbances in dialysis patients. J Nephrol (2008) 0.84
Effects of restless legs syndrome on quality of life and psychological status in patients with type 2 diabetes. Diabetes Educ (2010) 0.83
Stroke incidence and 30-day and six-month case fatality rates in Udine, Italy: a population-based prospective study. Int J Stroke (2013) 0.81
Restless legs syndrome in dialysis patients: a comparison between hemodialysis and continuous ambulatory peritoneal dialysis. Neurol Sci (2012) 0.80
Sensory gating deficit assessed by P50/Pb middle latency event related potential in Alzheimer's disease. J Clin Neurophysiol (2006) 0.80
Association of body rolling, leg rolling, and rhythmic feet movements in a young adult: A video-polysomnographic study performed before and after one night of clonazepam. Mov Disord (2008) 0.80
Lacosamide for the treatment of epilepsy. Expert Opin Drug Metab Toxicol (2014) 0.79
Sarcoidosis as risk factor for cryptococcal meningitis in an apparently immunocompetent patient. Neurol Sci (2008) 0.79
Drugs with anticholinergic properties: a potential risk factor for psychosis onset in Alzheimer's disease? Expert Opin Drug Saf (2009) 0.79
Gabapentin enacarbil, a gabapentin prodrug for the treatment of the neurological symptoms associated with disorders such as restless legs syndrome. Curr Opin Investig Drugs (2009) 0.79
Polysomnographic Sleep Patterns in Children and Adolescents in Unresponsive Wakefulness Syndrome. J Head Trauma Rehabil (2015) 0.78
Are Early Seizures Predictive of Epilepsy after a Stroke? Results of a Population-Based Study. Neuroepidemiology (2015) 0.77
The acute effect of a low dosage of pramipexole on severe idiopathic restless legs syndrome: an open-label trial. Neuropsychobiology (2007) 0.77
Gabapentin enacarbil in restless legs syndrome. Drugs Today (Barc) (2010) 0.77
Restless legs syndrome: differential diagnosis and management with rotigotine. Neuropsychiatr Dis Treat (2009) 0.77
ADMET considerations for restless leg syndrome drug treatments. Expert Opin Drug Metab Toxicol (2012) 0.76
Clinical experience with pramipexole in the treatment of restless legs syndrome. Expert Opin Drug Metab Toxicol (2008) 0.76
Seizures with prolonged EEG abnormalities during an attack of migraine without aura. Headache (2007) 0.76
The use of rotigotine in the treatment of restless legs syndrome. Ther Adv Neurol Disord (2010) 0.75
Genetic heterogeneity in inherited spastic paraplegia associated with epilepsy. Am J Med Genet A (2003) 0.75
Investigational approaches to therapies for restless legs syndrome. Expert Opin Investig Drugs (2014) 0.75
ADMET considerations when prescribing novel therapeutics to treat restless legs syndrome. Expert Opin Drug Metab Toxicol (2014) 0.75
Serum Interleukin-10 Levels Correlate with Cerebrospinal Fluid Amyloid Beta Deposition in Alzheimer Disease Patients. Neurodegener Dis (2017) 0.75